Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Sodium Hydroxybutyrate Injection

Approval Number

国药准字H32023426

Company成都倍特药业股份有限公司

Registration Date

December 17, 2020

Previous Approval Numbers

国药准字H32023426

Drug Information

Generic Name

羟丁酸钠注射液

Dosage Form

注射剂(注射液)

Strength

10ml:2.5g

Drug Type

化学药品

Registration Date

December 17, 2020

Company Information

Applicant Company

Company Name成都倍特药业股份有限公司

Company Address

成都高新区和祥三街263号

Manufacturing Company

Company Name成都倍特药业股份有限公司

Company Address

成都市双流西南航空港经济开发区空港四路1166号小容量注射剂三车间小容量2号生产线

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy